Module XVI-D: The Masters Review of Cardiovascular Medicine Breakthroughs

December 11, 2020 to December 13, 2020

Module XVI-D: The Masters Review of Cardiovascular Medicine Breakthroughs

Module XVI-D: The Masters Review of Cardiovascular Medicine Breakthroughs is the fourth and final module within the Advanced Cardiology Certification. Fully revised to reflect the latest clinical updates and scientific research, this advanced module will feature Q&A discussions, recent literature reviews, protocol assessments, and treatment plan options. Designed to provide an in-depth and updated review of clinically valuable information, Module XVI-D will be organized into three main sections: cardiovascular updates in clinical medicine, clinical didactic presentations, and clinical case presentations. Led by a panel of some of the field’s most well-respected and renowned clinical experts, participants will complete the module with an actionable understanding surrounding a wide variety of clinically relevant topics including insulin resistance, dyslipidemia, obesity, coronary heart disease, inflammation and CVD, personalized CV medicine, and much more.

Target Audience

This course is designed for physicians (internal medicine, family medicine, endocrinologists, general medicine, and OB-GYN), pharmacists, physician assistants, nurses, nurse practitioners, and other healthcare professionals interested in learning about the advancements of preventative and anti-aging medicine. 

Learning Objectives

Upon completion of this module, the participants will:
  • Review CV diagnosis and testing for precision and personalized CV medicine
  • Review the role of nutrients and nutrient-drug depletions in CVD
  • Review the relationship between the kidney and cardiovascular disease
  • Review and be competent in the evaluation and relationship of obesity, inflammation and CVD
  • Review the pathophysiology, diagnosis and treatment of diabetes mellitus and its relationship to CVD
  • Explain the role of CoQ10 in CVD, hypertension, dyslipidemia, coronary heart disease and congestive heart failure
  • Identify the most accurate functional and laboratory testing in HPATGG dysregulation, and be able to assess critical transitions from health to disease
  • Discuss the normal function of homeostatic mechanisms related to stress and hormone production, and the role of gene/environment interactions
Course summary
Available credit: 
  • 24.00 AMA PRA Category 1 Credit™
    The George Washington University School of Medicine and Health Sciences is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
  • 24.00 Completion
Course opens: 
Course expires: 
Event starts: 
12/11/2020 - 6:30am
Event ends: 
12/13/2020 - 6:00pm

Joseph J. Lamb, MD

Dr. Lamb is Senior Physician at the Personalized Lifestyle Medicine Center by Metagenics in Gig Harbor, WA. He is the Principal Investigator for the LIFEHOUSE Study. He is a frequent speaker in Integrative Medicine CME settings and is a consultant for the Nutritional Supplement Industry.

Sara Gottfried MD

Dr. Gottfried is a board-certified gynecologist and physician scientist. She graduated from Harvard Medical School and the Massachusetts Institute of Technology, and completed residency at the University of California at San Francisco. Dr. Gottfried is a global keynote speaker who practices evidence-based integrative, precision, and functional medicine. She is Clinical Assistant Professor in Dept. of Integrative Medicine and Nutritional Sciences at Sidney Kimmel Medical College, Thomas Jefferson University, and Director of Precision Medicine at the Marcus Institute of Integrative Health. Her three New York Times bestselling books include: The Hormone Cure, The Hormone Reset Diet, Younger, and her latest, Brain Body Diet.

Filomena Trindade, MD, MPH

Dr. Trindade is a teacher, author, and international speaker in functional medicine. She is a graduate of the fellowship in Anti-Aging, Regenerative and Functional Medicine and teaches in the Fellowship (a Master’s program through the Morsani School of Medicine, University of South Florida).
In addition, she is faculty at the Institute for Functional Medicine (IFM). After obtaining her BA degree in Biology she went on to finish a Master’s in Public Health in the area of environmental health and epidemiology before starting medical school. She graduated first in her class in family practice from the University of California Davis School of Medicine and did her residency training in family practice at the U.C. San Francisco/Santa Rosa Program. She has been in clinical practice for over 20 years. Before starting her own private practice in 2004 in functional medicine she was the medical director of a non-profit organization that catered to the underserved. Her work has been published in Townsend Letter, Guide to Anti-Aging & Regenerative Medicine, Saúde Actual, and the Border Health Journal among others. She is currently very active in developing teaching programs in Functional Medicine in the USA, Latin America and Europe.

H. Robert Superko, MD, FACC, FAHA, FASPC

Dr. Superko’s research and clinical focus is on the metabolic and inherited aspects of coronary heart disease. He received his undergraduate degree from the University of California, San Diego, medical degree from the State University of New York-Stony Brook, and completed his internship, residency, and fellowship at the University of California, Davis. Over the past 35+ years he has completed multiple NIH trials including heart disease regression, coffee and lipoprotein metabolism, exercise and weight loss with a focus on lipoprotein subclass distribution, firefighter heart disease, and genetics. He served as Director of the Stanford University Lipid Research Clinic and Laboratory, the Director of the Cholesterol Research Center at the University of California-Berkeley, the Director of the American Heart Association Lipid Disorders Training Center, the Founder of Berkeley HeartLab, and Director of the Center for Human Genomics at the Saint Joseph’s Hospital/Mercer University in Atlanta, Georgia. His most recent investigation was the National Firefighter Heart Disease Prevention study which revealed metabolic and genetic contributors to the epidemic of coronary heart disease in firefighters. This work has now expanded to a National non-profit program that helps identify firefighters vulnerable to a sudden coronary event and works to prevent CHD events in this professional population that serves to protect the rest of us. Dr. Superko also served as the Chief Medical Officer of Celera corp. (human genome in 2001). He has published 166 manuscripts, authored 19 textbook chapters, and 130 invited presentations at National and International scientific meetings for a total of 320 publications. He is the receipient of many awards including the Larry King Physician Laurete award, the Montague Boyd Award for Best Research Article, and the Doc Hopkins award from the California American Heart Association for New Insights. He has published a book for the public entitled “Before the Heart Attacks” that explains advanced aspects of causes of heart disease that go beyond cholesterol. His publication, ‘Beyond LDL-C’ in Circulation 1996 alerted the community to the concept of residual risk following LDLC reduction and the need to think beyond LDL cholesterol. His current professional activity includes a clinic focused on premature CHD and familial CHD at PRIMA Heart in Monterey, California and continued research focused on the genetic and metabolic contributors to CHD in firefighters. He is particularly interested in working with the American Society of Preventive Cardiology in expanding programs that identify firefighters and law enforcement officers vulnerable to a sudden coronary event and preventing such events.

Douglas Harrington, MD

Dr. Douglas Harrington has over 30 years of experience in the research, development, commercialization, and expansion of innovative healthcare technology and services. As former President and Lab Director of Nichols Institute, Dr. Harrington expanded their molecular genetics, infectious disease, immunology, cytogenetic, and anatomic pathology offerings.
Dr. Harrington holds a number of patents including automated image analysis of residual cancer protein, catalytic heavy metal extraction, and biomarker assays for diagnosis and classification of cardiac disease. He has been involved as director or founder of multiple startup companies – from devices to molecular genetics focusing on immunology, cancer, and cardiology, where he has taken a number of new molecular technologies through state and federal regulatory approval.

Mark C. Houston, MD, MS, FACP, ABAARM

Dr. Mark Houston is the Director of the Hypertension Institute and Vascular Biology, Medical Director of the Division of Human Nutrition and Medical Director of Clinical Research at the Hypertension Institute in Nashville, TN. He is on the faculty and Director of the Advanced Cardiovascular Modules XVI A4M/MMI in the US and Director of the Cardiovascular Module 2 for A4M/MMI. He is a Clinical Instructor in the Department of Physical Therapy and Health Care Sciences at George Washington University (GWU) School of Medicine and Health Science. He served as an Assistant Professor of Medicine and then as an Associate Professor of Medicine from 1978-1990 at Vanderbilt University School of Medicine and was an Associate Clinical Professor of Medicine at Vanderbilt University School of Medicine, (VUMS) (1990-2012). He also served as an Adjunct Professor in Metabolic Medicine at the University of South Florida, Tampa (USF) Medical School (2014-2918)
Dr. Houston has four board certifications by the American Board of Internal Medicine (ABIM), the American Society of Hypertension (ASH) (FASH-Fellow), the American Board of Anti-Aging and Regenerative Medicine (ABAARM, FAARM) and American Board of Cardiology (ABC) Certification in Hypertensive Cardiovascular Disease (DABC). He holds two Masters of Science degrees in Human Nutrition from the University of Bridgeport, CT (MS) and another in Metabolic and Nutritional Medicine (University of South Florida School of Medicine-Tampa (MSc).
He was selected as one of the top physicians in the US in Cardiovascular Medicine in 2018 by the US Consumer Research Council. Dr. Houston was also named as one of the Top Physicians in Hypertension in the US in 2008-2014 by the Consumer Research Council. He was honored by USA Today as one of the Most Influential Doctors in the US in both Hypertension and Hyperlipidemia twice in 2009 and 2010. Dr. Houston was selected as The Patient’s Choice Award in 2010 -2012 by Consumer Reports USA. He was selected as one of the Top 100 physicians in the US by the American Health Council in 2017 and one of the Top 50 Functional and Integrative Medical Doctors in the USA in August 2017. He was also named one of America’s Best Physicians in Cardiology 2018 by the National Consumer Advisory Board. In 2019 he was elected to the Continental WHO’S WHO as a Top Doctor in the field of Medicine as the Medical Director and Founder of the Hypertension Institute.
Dr. Houston has presented over 10,000 lectures, nationally and internationally and published over 250 medical articles, scientific abstracts in peer reviewed medical journals, books and book chapters. He is an author, teacher, clinician and researcher.

James LaValle, RPh, CCN

James LaValle, is an internationally recognized clinical pharmacist, author, board certified clinical nutritionist, and expert and educator in integrative and precision health. James is best known for his expertise in personalized integrative therapies uncovering the underlying metabolic issues that keep people from feeling healthy and vital. A thought leader in drug/nutrient depletion issues he has published 4 books and 3 databases in this area alone. As such he has over 35 years’ experience integrating natural and integrative therapies into various medical and business models. His latest research is in drug induced microbiome disruption.
He has served thousands of patients, using his metabolic model for health, in his personal integrative health practices, currently at LaValle Metabolix in Orange County, CA, and formerly at LaValle Metabolic Institute, an interdisciplinary medicine facility which he founded in Cincinnati in 2001 and sold in 2014. His experience spans from the super athlete to individuals struggling with chronic health complaints. organizations and and athletes from the Chicago Blackhawks, Anaheim Ducks, San Jose Sharks, Toronto Maple Leaf’s Orlando Magic, Philadelphia Eagles, New England Patriots, Houston ASTROS, ST. Louis Cardinals as well as athletes from Olympians, to collegiate baseball, basketball and football, car racing all search out his expertise for optimizing metabolism and targeting real world results. He was selected to be Integrative Medicine Program Director for the NFL Hall of Fame Health and Performance Program in 2019. He also educates and works with military Special forces to optimize resilience and metabolic reserve.

Stephen Sinatra, MD, FAAC, CNS

Dr. Stephen T. Sinatra is a board-certified cardiologist and an Assistant Clinical Professor of Medicine at the University of Connecticut School of Medicine in Farmington, Connecticut. Certified as a bioenergetic psychotherapist, and nutrition and anti-aging specialist, Dr. Sinatra integrates psychological, nutraceutical and electroceutical therapies in the matrix of healing. He is the founder of, an informational website dedicated to promoting public awareness of integrative medicine. Dr. Sinatra is a fellow in the American College of Cardiology and the American College of Nutrition. Dr. Sinatra’s latest book, co-authored with Tommy Rosa, is Health Revelations from Heaven and Earth.
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of The George Washington University School of Medicine and Health Sciences and the American Academy of Anti Aging Medicine. The George Washington University School of Medicine and Health Sciences is accredited by the ACCME to provide continuing medical education for physicians.
The George Washington University School of Medicine and Health Sciences designates this live activity for a maximum of 24 AMA PRA Category 1 Credit(s) ™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Available Credit

  • 24.00 AMA PRA Category 1 Credit™
    The George Washington University School of Medicine and Health Sciences is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
  • 24.00 Completion
Please login or register to take this course.

Required Hardware/software

Technical Requirements:

  • High-speed internet connection
  • Browsers:
  • This educational activity has been tested in the latest versions of Internet Explorer, Edge, Firefox, Safari, and Chrome browsers on Windows or Macintosh computers.
  • Safari, Firefox, or Chrome browsers are recommended for the best results.
  • Internet Explorer browser is not recommended. If you must use Internet Explorer, please update to version 11, which is the only version supported by Microsoft at this writing.
  • Latest version of Adobe Reader to view PDF documents.